ETICOVO Trademark

Trademark Overview

On Thursday, August 14, 2025, a trademark application was filed for ETICOVO with the United States Patent and Trademark Office. The USPTO has given the ETICOVO trademark a serial number of 99336992. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, January 6, 2026. This trademark is owned by Samsung Bioepis Co., Ltd.. The ETICOVO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for medical use, namely, pharmaceutical preparations for immunoregulation, for treatment of autoimmune diseases, for use as anti-cancer agents, for treatment of cancer, for treatment of tumors, for treatment of central nervous system disorders and for treatment of metabolic diseases; pharmaceutical preparations for treating human immune diseases and conditions; pharmaceutical preparations for treating inflammatory diseases and conditions; pharmaceutical preparations for treating arthritis; pharmaceutical preparations for treating rheumatoid arthritis; pharmaceutical preparations for treating psoriatic arthritis; pharmaceutical preparations for treating ankylosing spondylitis; pharmaceutical preparations for treating psoriasis; pharmaceutical preparations for treating polyarticular juvenile idiopathic arthritis; pharmaceutical preparations for treating enthesitis-related arthritis
eticovo

General Information

Serial Number99336992
Word MarkETICOVO
Filing DateThursday, August 14, 2025
Status641 - NON-FINAL ACTION - MAILED
Status DateTuesday, January 6, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations for medical use, namely, pharmaceutical preparations for immunoregulation, for treatment of autoimmune diseases, for use as anti-cancer agents, for treatment of cancer, for treatment of tumors, for treatment of central nervous system disorders and for treatment of metabolic diseases; pharmaceutical preparations for treating human immune diseases and conditions; pharmaceutical preparations for treating inflammatory diseases and conditions; pharmaceutical preparations for treating arthritis; pharmaceutical preparations for treating rheumatoid arthritis; pharmaceutical preparations for treating psoriatic arthritis; pharmaceutical preparations for treating ankylosing spondylitis; pharmaceutical preparations for treating psoriasis; pharmaceutical preparations for treating polyarticular juvenile idiopathic arthritis; pharmaceutical preparations for treating enthesitis-related arthritis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 14, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSamsung Bioepis Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressIncheon 21987
KR

Trademark Events

Event DateEvent Description
Thursday, August 14, 2025NEW APPLICATION ENTERED
Thursday, August 14, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 14, 2025APPLICATION FILING RECEIPT MAILED
Monday, December 29, 2025ASSIGNED TO EXAMINER
Tuesday, January 6, 2026NON-FINAL ACTION WRITTEN
Tuesday, January 6, 2026NON-FINAL ACTION E-MAILED
Tuesday, January 6, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED

Related Keywords

eticovo preparations pharmaceutical treating treatment arthritis diseases conditions cancer idiopathic enthesitis